ShangBay Capital LLC
Venture capitalPalo Alto · Seed–Series A · 12 people tracked
Find your way into ShangBay Capital LLC
786 people in our graph share verified history with the ShangBay Capital LLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
ShangBay Capital focuses on backing founders who build disruptive companies targeting large, unmet clinical needs through novel approaches. The firm cultivates relationships with investors, entrepreneurs, KOLs, strategics, and industry innovators, and leverages a leadership team with a combined 100+ years of experience and deep ties to strategics and innovators in disruptive technologies. Its aim is to help founders address significant market needs while generating favorable returns.
Source: firm website, verified Sep 15, 2026.
Team · 12 people
from the firm's website & curated & public directories
What they invest in
from 52 of 70 portfolio companiesHealthtech ×39Medical Devices ×36Biotech ×25Deep Tech ×12Digital Health ×9Hardware ×7AI & Machine Learning ×6Robotics ×3
HQs:United States×41Canada×1China×1Germany×1Israel×1New Zealand×1
Who they back
founder profiles across 33 portfolio companiesFounding team size:solo founder×172 founders×123 founders×4
Where their founders studiedfrom 24 founders with education data
Stanford University ×4California Polytechnic State University-San Luis Obispo ×2Harvard University ×2Pepperdine University ×2Stanford University Graduate School of Business ×2University of California, Berkeley ×2
What their founders studiedfrom 24 founders with field-of-study data
Engineering ×14Business & Management ×4Life Sciences ×4Medicine ×4Computer Science ×3Chemistry ×2Finance & Accounting ×2
Where their founders worked beforefrom 25 founders with career history
Invisalign ×2
Accelerator rootsportfolio companies that came through a program
10 founders hold a PhD · 8 hold an MBA (of 25 with degree data)
Investments · 70 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 42023 · 32021 · 22020 · 32019 · 32016 · 22014 · 123 dated
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSunnyvale, US
Josef Parvizi(Director)inXingjuan (Jane) Chao(President, CEO, Co-Founder & Director)inScott Blumberg(Executive Officer)inJoseph Taylor(Director)Raymond Woo(Executive Officer)David Stoffel(Executive Officer)
Co-investorsLongitude CapitalRA CapitalRed Tree VentureThe Rise Fund
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.
BiotechHealthtechHouston, US
David J. Tweardy(Executive Officer, Director)Josef Schoell(Executive Officer)inJoseph W. Stauffer(Executive Officer)Derek Chalmers(Executive Officer, Director)inMichael E. Lewis(Executive Officer)inFrederique Menzaghi(Executive Officer)
Co-investorsSolas BioVentures
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.
BiotechDigital HealthHealthtechMedical DevicesAspen, US
Scott Xiao(Co-Founder & CEO)inDean Travers(Co-Founder)inBrion Raymond(CBO)inDrew Mowery(VP of Commercial Strategy)inHank Wu(COO)inSunny Atwal(VP of Engineering)in
Co-investorsBantam GroupGood FriendsNXT VenturesSony Ventures CorporationUS Venture PartnersU.S. Venture Partners
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)
BoardFrederic Moll(Director)Rony Abovitz(Co-founding Advisor)
Co-investorsTSVCDolma VenturesK50 VenturesSonder CapitalSonder Futures
Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma.
Deep TechHealthtechMedical Devices
Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prash Chopra(Founding CEO & Director)Frederic H. Moll(Director)Rony Abovitz(Co-founding Advisor)
Co-investorsTSVCHike VenturesK50 Ventures
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+9 more
Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories.
BiotechHealthtechMedical DevicesMenlo Park, US
Dongliang Ge(Executive Officer, Director)Xin Guo(Director)Bo Zhang(Executive Officer, Director)
BoardWilliam Dai(Director)in
Co-investorsAmino Capital
-2.png)
Aranz Medical is a company that provides clinical research and wound care solutions, as evidenced by their collection of clinical research posters on wound assessment, management, and documentation across healthcare settings.
Digital HealthHealthtechMedical Devices
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesArboretum VenturesAvestria Ventures
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)inIgor Khandros(Executive Officer, Director)
BoardMichael Marks(Director)inLip-Bu Tan Tan(Director)Michael Moritz(Director)inWilliam Davidow(Director)
Co-investorsCelesta CapitalCelesta CapitalCota CapitalKhosla VenturesOpen Field CapitalWalden Catalyst+5 more
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy.
BiotechHealthtech
Co-investorsSand Hill AngelsPureTech Health
CloudMedx uses machine learning, natural language understanding, and healthcare-specific fine-tuned LLMs to analyze healthcare data and generate clinical, operational, and financial insights.
AI & Machine LearningDigital HealthHealthtechPalo Alto, US
Tashfeen Suleman(Executive Officer)Sahar Arshad(Director)
Co-investorsDFJ DragonFundFundersClub
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin Eisenfrats(Co-Founder and CEO)inJohn Herr(Co-Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)inMartin J Emerson(Director)Tom Thorpe(Director)
Co-investorsBiotechnology Value FundMBX CapitalAllied Venture PartnersAmboy Street VenturesAurum Venture PartnersBeni Venture Capital+15 more
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)in
Co-investorsAbstract VenturesArtis VenturesJ12 VenturesAccompliceCatalyst Health VenturesCosmic Venture Partners+15 more
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems.
HardwareHealthtechMedical DevicesFremont, US
BoardErik Engelson(Director)Michael Wallace(Executive Officer, Director)Skott Greenhalgh(Director)
Co-investorsAPERTURE Venture PartnersNorwest Venture Partners
Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.
BiotechHealthtechMedical DevicesShanghai, CN
Wu Chenbing(Founder/Expert)
Co-investorsDecheng CapitalTCG Labs3E Bioventures CapitalSherpa Healthcare Partners
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers.
FemTechHealthtechMedical Devices
Co-investorsPortfoliaSv Tech Ventures, Inc.
Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells.
AI & Machine LearningBiotechDeep TechHealthtech
Jim Audia(Executive Vice President, Drug Discovery and Early Development, and Founding Scientist)Jacob Stuckey(Senior Director, Biochemistry and Chemical Biology, and Founding Scientist)in
Co-investorsNexTech VenturesPfizer VenturesThird Rock VenturesNextech InvestPfizer Venture InvestmentsAgent Capital
Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke.
BiotechDeep TechHealthtechMedical DevicesCalgary, CA
Dr. John H. Wong(Co-founder & Chief Executive Officer)Dr. Alim P. Mitha(Co-founder, President & Chief Technology Officer)
Co-investorsAccelerate FundLifeArc VenturesThin Air LabsUCeed FundsAmplitude Venture CapitalIAG Capital Partners
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Co-investorsKhosla VenturesAllerfund Ventures, LlcFemHealth VenturesGlobal BrainMedical Incubator Japan K.K.Alexandria+1 more
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsNorthern Light Venture CapitalVivo CapitalTriWise Capital
Inquis Medical is a medical device company developing minimally invasive technology to treat thromboembolic disease in the cardiovascular and vascular space.
Deep TechHardwareHealthtechMedical DevicesMenlo Park, US
Vahid Saadat(CEO)inMojgan Saadat(Co-founder)in
BoardDavid A. Lamond(Chairperson of the Board)
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)in
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsAphelion CapitalFeatures Capital Holdingsgener8torAphelion CardeationEngage Venture PartnersUnorthodox Ventures
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inJohn R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)Justin Butler(Director)Tuff Yen(Director)Steve Tablak(Director)
Co-investors11.2 CapitalForesite CapitalY CombinatorOS Fund
Magnetic Particle Imaging (MPI) is an imaging technology that detects iron oxide nanoparticle tracers using time-varying magnetic fields to create medical images with high contrast and sensitivity.
Deep TechHealthtechMedical Devices
Co-investors5AM VenturesEvolution VC PartnersInnolinks VenturesSand Hill AngelsCelesta CapitalWestlake Village BioPartners
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Co-investorsAgent CapitalLongwood FundMission BiocapitalNovartis Venture FundOno Venture Investment, Inc.Pfizer Venture Investments+3 more
Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Alex Tilson(Founder & CEO)in
Co-investorsSonder CapitalInCube VenturesMighty Capital
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesUS Venture PartnersAmzak Health
neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.
Deep TechHealthtechMedical DevicesSan Francisco, US
Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsFrontier Path VCSonder Capital
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions.
Deep TechHealthtechMedical DevicesCalifornia, US
JIANLU MA(Executive Officer, Director)
BoardLU GANG(Director)WILLIAM DAI(Director)inJEFF PETERS(Director)DAVE FERRERA(Director)
Co-investorsSv Tech Ventures, Inc.
Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Jian Zhang(Founder & CEO)Enrique RomoinFrank Grilloin
Co-investors1955 CapitalChina Growth CapitalLYFE CapitalProsperity7 Ventures
OrthoFX makes AirFlex, an FDA-cleared clear aligner system that straightens teeth with at least 12 hours of continuous daily wear using a patented elastic polymer for lower force.
ConsumerDigital HealthHealthtechMedical DevicesNew MaterialsFremont, US
Nichole Garcia(Founder)inRen Menon(Founder)inHenry Chan(Founder)in
Co-investorsXRCSignalFireUnusual Ventures
Petal offers credit card products aimed at helping people access credit, including those new to credit or with past credit issues, by using their savings and spending data to assess creditworthiness beyond a traditional credit score.
ConsumerFintechOxford, US
David Michael Melnick Taffet(Executive Officer)
Co-investorsAfore CapitalEvolution VC PartnersFairhaven Capital PartnersNelstone VenturesNew Ground VenturesRosecliff Ventures+6 more
Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery.
BiotechHealthtechMedical DevicesCambridge, US
James (Tony) Stefater(Founder)inTony Stefater, MD, PhD(President & Cofounder)Tommy Stryjewski, MD(Chief Scientific Officer, Cofounder, Director)James A. Stefater(Executive Officer)inMichael Singer(Director)Richel Liu(Director)
Co-investorsBeacon Angels
Radiaction Medical develops a plug-and-play radiation protection device for interventional medical staff that reduces scatter radiation at the source, with FDA Class II clearance for use in the United States, European Union, and United Kingdom.
Deep TechHardwareHealthtechMedical DevicesTel Aviv, IL
Amir Belson(Founder)in
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
BoardBlake Wu(Director)inJuan-Pablo Mas(Director)in
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta Capital+5 more
Skyhawk Therapeutics develops RNA-targeting small molecule drugs using its SKYSTAR platform to modify RNA expression, addressing diseases in neurology, oncology, and fibrotic conditions.
BiotechDeep TechWaltham, US
Kathleen McCarthy(Founder)
Co-investorsAgent CapitalDns CapitalGood Growth CapitalGreatPoint Ventures
Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.
Medical DevicesCollege Station, US
James Y Lancaster(Executive Officer, Director)in
BoardJohn Hodock(Director)Robert Calvin Goforth(Director)
Co-investorsSugati VenturesJohnson & Johnson Innovation – JJDC
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment.
BiotechHealthtechMedical DevicesChapel Hill, US
Daniel Estay(Executive Officer, Director)inWilliam N. Starling(Director)
Co-investorsBand of AngelsWolfpack Investor Network
SoundHealth develops FDA 510(k) cleared, drug-free medical devices that use acoustic resonance therapy via forehead bone conduction to treat nasal congestion and improve sleep.
AI & Machine LearningDigital HealthMedical Devices
Paramesh Gopi, PhD(Founder & CEO)Bryant Lin, MD, MEng(Founder & Head of Clinical Affairs and Product Design)Peter Hwang, MD(Founder & Head of Research)
Co-investorsG Vision CapitalJ4 VenturesMoai CapitalTau Ventures
Sporos Bioventures is a private biotechnology company that uses a portfolio approach to drug development in oncology, holding equity stakes in biopharma entities such as Tvardi Therapeutics and Sporos BioDiscovery.
BiotechHealthtechHouston, US
Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options.
HealthtechMedical DevicesMenlo Park, US
Karen Havenstrite(Director)inVictor McCray(Executive Officer, Director)
BoardDouglas Crawford(Director)inHanson Gifford(Director)Chip Heath(Director)Brandon Felkins(Director)
Co-investorsMission BiocapitalLightstone Ventures
Telesair develops medical devices focused on patient care, with work spanning strategy, design, engineering, and quality assurance.
AI & Machine LearningHardwareHealthtechMedical DevicesIrvine, US
Don Lin(Co-founder & CEO)inKen Wang(Executive Officer, Director)inDongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)inJing Zhang(Director)Bo Li(Director)
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)in
BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in
Co-investorsAphelion CapitalCadence Healthcare VenturesCatalyst Health Ventures
Window Therapeutics is a biotechnology company developing therapeutics for cancer and other life-threatening diseases, based on its bottle-brush-analogue-macromonomer (BAM) technology.
BiotechDeep TechHealthtechBoston, US
James Lu(Director)Jeremiah Johnson(Founder (based on BAM technology from his MIT lab))Lusong Luo(Director)Chih-Kao Hu(Executive Officer, Director)
BoardKenneth C. Anderson(Professor, Researcher and Clinician, Harvard Medical School & DFCI)
YorLabs develops an intracardiac echocardiography (ICE) ultrasound imaging system aimed at interventional cardiology and electrophysiology procedures.
Digital HealthHardwareMedical DevicesBeaverton, US
Clark Brooks(Founder)Sunit Rikhi(Founder)
ZAP Surgical develops the ZAP-X Gyroscopic Radiosurgery platform, a self-shielded surgical robotics system for non-invasive cranial stereotactic radiosurgery (SRS) that uses linear accelerator technology instead of radioactive sources.
HealthtechMedical DevicesRobotics
John R. Adler, Jr.(Founder)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaF-Prime CapitalY CombinatorDorm RoomGolden SeedsMedical Technology Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlleviantApexigenAqua MedicalArrinexAtia VisionBriusCorinth MedtechEarly Bird MedicalEmbolineFrond MedicalMeditrinaModular SurgicalPiezolabsPresidio MedicalQuandxRefuge BiotechRestera MedicalSentiré Medical SystemsSightStreamTioga MedicalTrueBindingZeto
Exits · 3
3 IPOs · showing 2CeribellNASDAQ: CBLLTvardi TherapeuticsNASDAQ: TVRD
Portfolio news
latest coverage across their companiesCeribell · investing.com · Sep 11, 2026
Apostle · nairobileo.co.ke · Sep 5, 2026
Tvardi Therapeutics · stocktitan.net · Aug 26, 2026
Cure · beautyindependent.com · Aug 20, 2026
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Sound Health · sleepreviewmag.com · Aug 19, 2026
Contraline · fiercebiotech.com · Aug 12, 2026
Petal · whalesbook.com · Aug 5, 2026
Frequently asked questions
- How many investments has ShangBay Capital LLC made?
- ShangBay Capital LLC has 70 tracked investments, 3 of which have exited, including 7 dated in the last 24 months.
- What stage does ShangBay Capital LLC invest at?
- ShangBay Capital LLC invests at the Seed, Series A stages.
- What sectors does ShangBay Capital LLC focus on?
- ShangBay Capital LLC focuses on Biotech, Healthtech, Medical Devices.
- Where is ShangBay Capital LLC located?
- ShangBay Capital LLC is headquartered in Palo Alto, US.
- Does ShangBay Capital LLC lead rounds?
- ShangBay Capital LLC has led 3 of the 7 rounds where its role is on record.
- Who does ShangBay Capital LLC co-invest with?
- ShangBay Capital LLC most often shares deals with RA Capital, Mission Biocapital, New Enterprise Associates (NEA), among 103 tracked co-investors.
- What size deals does ShangBay Capital LLC back?
- Across 7 deals with disclosed amounts, ShangBay Capital LLC has joined rounds of $8M – $64M (median $22M).
Co-investors · 7
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Sony Innovation Fund is the corporate venture capital arm operated by Sony Ventures Corporation, investing in technology and entertainment startups worldwide.
Action Potential Venture Capital is a corporate venture fund backed by GSK that invests in peripheral neuromodulation medical devices and bioelectronics technologies.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Firms observed investing alongside ShangBay Capital LLC, from public investor directories. Shared companies are the overlap with ShangBay Capital LLC's recorded portfolio.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.